Table 2.
1-Stage Latissimus Only n = 28 48.30% | 1-Stage Latissimus with Implant n = 7 12.10% | 2-Stage Latissimus with TE/Implant n = 8 13.80% | 3-Stage Latissimus with Delayed TE/Implant n = 15 25.90% | P | |
---|---|---|---|---|---|
Any complication | 4 (14.3%) | 2 (28.6%) | 5 (52.5%) | 4 (26.7%) | 0.055 |
Capsular contracture, grades 3 and 4 | – | 1 (14.3%) | 2 (25%) | 1 (6.7%) | 0.467 |
Mastectomy flap necrosis | 1 (3.6%) | 0 | 0 | 0 | 0.779 |
Wound dehiscence | 1 (3.6%) | 0 | 0 | 0 | 0.779 |
Implant exposure | – | 1 (14.3%) | 0 | 0 | 0.183 |
Seroma, any | 0 | 0 | 2 (25%) | 2 (12.3%) | 0.054 |
Seroma, breast | 0 | 0 | 1 (12.5%) | 1 (6.7%) | 0.297 |
Seroma, back | 0 | 0 | 1 (12.5%) | 1 (6.7%) | 0.297 |
Hematoma | 1 (3.6%) | 0 | 0 | 0 | 0.779 |
Partial flap loss | 1 (3.6%) | 0 | 0 | 0 | 0.779 |
Infection | 1 (3.6%) | 0 | 1 (12.5%) | 1 (6.7%) | 0.689 |
Implant malposition | – | 0 | 1 (12.5%) | 0 | 0.241 |
Explantation | – | 1 (14.3%) | 1 (12.5%) | 0 | 0.339 |
Reoperation | 3 (10.7%) | 1 (14.3%) | 2 (25%) | 0 | 0.295 |